20/20 BIOLABS, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
20/20 BIOLABS, INC. (AIDX) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $1.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2026-08-14
- 20/20 BIOLABS, INC. adjustments to additional paid in capital, convertible debt with conversion feature for the quarter ending 2026-03-31 was $1.00M.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 3 month |
|---|---|
| 2026-03-31 | $1.00M 10-Q · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |